Report error Found 55 Enz. Inhib. hit(s) with all data for entry = 12047
Affinity DataIC50: 40.3nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 46.9nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 72.8nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 95.6nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 207nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 273nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 335nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 353nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 452nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 492nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 544nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 561nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 770nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 807nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 951nMAssay Description:VHL/elongin B/elongin C were constructed, expressed and purified, and VHL was labeled. PHD1, PHD2 and PHD3 were constructed, expressed and purified. ...More data for this Ligand-Target Pair
Affinity DataIC50: 3.79E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds of the present disclosure were subjected to the CYP450 enzyme inhibition assay. The experimental results showed that the compounds of t...More data for this Ligand-Target Pair
